| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TRA2A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | OSER1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | LIG3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | DDX21 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TET3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FEM1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | IGF2BP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SH3PXD2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | EPB41L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TMCO3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
